10% af valdecoxibkoncentrationen; på grund af denne metabolits lave koncentration forventes den ikke at bidrage med en klinisk signifikant effekt efter administration af parecoxibnatrium i terapeutiske doser.
It represents approximately 10% of the concentration of valdecoxib; because of this metabolite’ s low concentration, it is not expected to contribute a significant clinical effect after administration of therapeutic doses of parecoxib sodium.